CIK 0001770121
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831381173
- Phone
- +1 206-701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- 4 Open-market sale 10% owner sold 545,242 shares at an average $6.47 ($3,527,275)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,314 shares (grant or award)
- 4 Grant or award Director acquired 7,716 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at $25.00 ($500,000)
- 4 Grant or award Director acquired 536 shares (grant or award)
- 4 Grant or award Director acquired 6,702 shares (grant or award)
- 4 Grant or award Director acquired 321 shares (grant or award)
- 4 Grant or award Director acquired 4,012 shares (grant or award)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 3,328 shares (grant or award)
- 4 Grant or award Director acquired 266 shares (grant or award)
Page 6 of 10 · 193 filings